Related Experiment Videos
Nanging
1Department of Neurology, Auckland Hospital, Auckland 1, New Zealand. huanghc@hotmail.com
Lancet (London, England)
|September 21, 2002
Summary
No abstract available in PubMed .
Related Concept Videos
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Immunoglobulin A vasculitis in association with invasive meningococcal disease: a case report.
Modern rheumatology case reports·2026
Same author
Phase 3 Trial of Secukinumab in Polymyalgia Rheumatica.
The New England journal of medicine·2026
Same author
Feasibility, Safety and Preliminary Efficacy of 1:1 THC:CBD Cannabis Oil for Fibromyalgia Symptoms: Results From a Randomised, Double-Blind, Placebo-Controlled Pilot Trial.
Pain research & management·2026
Same author
Assessing the feasibility and acceptance of the Deaf in Touch Everywhere (DITE™) mobile app: Insights from healthcare simulations and stakeholder discussions (HEARD project).
Digital health·2026
Same author
An updated and expanded characterization of the biological sciences academic job market.
Frontiers in research metrics and analytics·2024
Same journal
Assisted dying and the silencing of medicine's next generation.
Lancet (London, England)·2026
Same journal
Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.
Lancet (London, England)·2026
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)·2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)·2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)·2026